Načítá se...
Vasopressin antagonist efficacy and safety in volume-overloaded critically ill patients: a new therapeutic alternative
OBJECTIVES: To assess tolvaptan’s efficacy and safety in critical care patients with volume overload. METHODS: Prospective observational study. Twenty-eight patients in the recovery phase from multiple organ failure and with volume overload refractory to conventional therapy treated with tolvaptan w...
Uloženo v:
| Vydáno v: | Eur J Hosp Pharm |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7223349/ https://ncbi.nlm.nih.gov/pubmed/32419936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-001664 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|